
Huw Edwards, CEO of ukactive (Image: ukactive)
A coalition of international health and fitness organisations, including ukactive, is calling on governments and health systems to ensure obesity medications are delivered alongside funded physical activity and nutrition support, rather than as standalone treatments.
The World Obesity Federation, ukactive, the Health & Fitness Association, AUSactive, Exercise New Zealand and the Fitness Industry Council of Canada have issued a joint position statement outlining a global framework for integrating prevention, treatment and long-term health outcomes. With almost three billion adults worldwide currently overweight or living with obesity, projected to reach four billion by 2035, the organisations stress that while medications such as GLP-1 therapies represent a major clinical advance, they must be embedded within comprehensive care models.
The statement warns that reliance on medication alone risks poorer long-term outcomes, including muscle loss, reduced functional capacity and widening health inequalities where access to support services is limited. Instead, it advocates a ‘wraparound’ approach combining pharmacological treatment with sustained investment in physical activity, nutrition and supportive environments.
It also calls for obesity medications to be integrated into care pathways that include funded lifestyle support, alongside continued investment in prevention and community programmes. Policymakers are urged to prioritise equitable access, measure outcomes beyond weight alone, and align health and economic policy to reflect the long-term value of prevention.
Huw Edwards, CEO of ukactive said: “The global rise of obesity medications must not be viewed as a substitute for physical activity and nutrition when in fact it heightens the need for these vital elements.
“Research shows the risks of relying solely on weight-loss drugs and the critical need for physical activity and nutrition to form part of every treatment programme.
“This represents a huge opportunity in the UK and globally for our political leaders to integrate physical activity, nutrition and medication to combat obesity and the harm it causes.
“We have the infrastructure of gyms, swimming pools, leisure centres and other fitness services in every community, ready to support GLP-1 patients during and after treatment.”
The organisations position the sector as a key delivery partner, highlighting the existing infrastructure of gyms, leisure centres and community facilities that can support individuals during and after treatment. They also emphasise that investment in physical activity and nutrition delivers wider population health benefits, supporting both prevention and long-term system sustainability.
Johanna Ralston, CEO of the World Obesity Federation, said: “GLP-1 therapies are an important advance in obesity care, but they cannot succeed in isolation.
“People with obesity demand and deserve access to good nutrition and physical activity support and advice, to support lasting rather than short-term health improvements.
“Governments must ensure these treatments are embedded within comprehensive, person-centred systems of care.”
The coalition says it will work with governments and stakeholders to advance integrated, evidence-based approaches that improve health outcomes and ensure obesity care is both effective and sustainable.
Liz Clark, President and CEO of the Health & Fitness Association, added: “This is an opportunity to properly position our sector as an essential partner in prevention and care while ensuring individuals retain the freedom to engage in physical activity in the environments where they feel most comfortable.”
Read the full statement here: https://ukactive.com/news/global-health-and-fitness-leaders-call-for-physical-activity-and-nutrition-to-be-central-to-obesity-medication-rollout/



